The precision prevention and therapy of HPV‐related cervical cancer: new concepts and clinical implications

Z Hu, D Ma - Cancer medicine, 2018‏ - Wiley Online Library
Cervical cancer is the third most common cancer in women worldwide, with concepts and
knowledge about its prevention and treatment evolving rapidly. Human papillomavirus …

Clinical implications of (epi) genetic changes in HPV-induced cervical precancerous lesions

RDM Steenbergen, PJF Snijders… - Nature Reviews …, 2014‏ - nature.com
Infection of cervical epithelium with high-risk human papilloma virus (hrHPV) might result in
productive or transforming cervical intraepithelial neoplasia (CIN) lesions, the morphology of …

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

HA Katki, WK Kinney, B Fetterman, T Lorey… - The lancet …, 2011‏ - thelancet.com
Background Concurrent testing for human papillomavirus (HPV) and cervical cytology (co-
testing) is an approved alternative to cytology alone in women aged 30 years and older. We …

Eurogin roadmap 2017: triage strategies for the management of HPV‐positive women in cervical screening programs

K Cuschieri, G Ronco, A Lorincz, L Smith… - … journal of cancer, 2018‏ - Wiley Online Library
Cervical cancer screening will rely, increasingly, on HPV testing as a primary screen. The
requirement for triage tests which can delineate clinically significant infection is thus …

Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis

H Kelly, Y Benavente, MA Pavon, S De Sanjose… - British journal of …, 2019‏ - nature.com
Background To conduct a meta-analysis of performance of DNA methylation in women with
high-grade cervical intraepithelial neoplasia (CIN2+). Methods Medline and Embase …

Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised …

VMJ Verhoef, RP Bosgraaf, FJ van Kemenade… - The lancet …, 2014‏ - thelancet.com
Background Cytology is a widely used method of triaging women who test positive for
human papillomavirus (HPV). However, self-sampled specimens, which can substantially …

[HTML][HTML] Virtues and weaknesses of DNA methylation as a test for cervical cancer prevention

AT Lorincz - Acta cytologica, 2016‏ - karger.com
Epigenetics is the study of heritable and non-heritable genetic coding that is additive to
information contained within classical DNA base pair sequences. Differential methylation …

Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts

VV Sahasrabuddhe, P Luhn, N Wentzensen - Future microbiology, 2011‏ - Taylor & Francis
While organized screening programs in industrialized countries have significantly reduced
cervical cancer incidence, cytology-based screening has several limitations. Equivocal or …

New technologies and procedures for cervical cancer screening

J Cuzick, C Bergeron, M von Knebel Doeberitz… - Vaccine, 2012‏ - Elsevier
The clearly higher sensitivity and reproducibility of human papillomavirus (HPV) DNA testing
for high-grade cervical intraepithelial neoplasia (CIN) has led to widespread calls to …

Predicting hub genes associated with cervical cancer through gene co-expression networks

SP Deng, L Zhu, DS Huang - IEEE/ACM Transactions on …, 2015‏ - ieeexplore.ieee.org
Cervical cancer is the third most common malignancy in women worldwide. It remains a
leading cause of cancer-related death for women in develo** countries. In order to …